The derivation and characterization of a neuroattenuated reassortant clone (RFC 25/B.5) of California serogroup bunyavirus was described previously (M. J. Endres, A. Valsamakis, F. Gonzalez-Scarano, and N. Nathanson, J. Virol. 64:1927-1933 is the major determinant of neuroattenuation of clone B.5. In addition to its neuroattenuation, clone B.5 was temperature sensitive and exhibited an altered plaque morphology. These phenotypes also segregated with the large RNA segment. The importance of the large RNA segment (which encodes the viral polymerase) in neurovirulence contrasts with prior studies which indicate that the ability to cause lethal encephalitis after peripheral injection of suckling mice (neuroinvasiveness) is primarily determined by the middle-sized RNA segment, which encodes the viral glycoproteins.
The derivation and characterization of a neuroattenuated reassortant clone (RFC 25/B.5) of California serogroup bunyavirus was described previously (M. J. Endres, A. Valsamakis, F. Gonzalez-Scarano, and N. Nathanson, J. Virol. 64:1927-1933, 1990 ). To map the RNA segment responsible for this attenuation, a panel of reassortants was constructed between the attenuated clone B.5 (genotype TLL) and a virulent clone (Bl-la) of reciprocal genotype (LTT). Parent viruses and clones representing all of the six possible reassortants were examined for neurovirulence by intracerebral injection in adult mice. Reassortants bearing the large RNA segment from the virulent parent were almost as virulent as the virulent parent virus, while reassortants bearing the large RNA segment from the avirulent parent virus exhibited low or intermediate virulence. These results indicate that the large RNA segment is the major determinant of neuroattenuation of clone B.5. In addition to its neuroattenuation, clone B.5 was temperature sensitive and exhibited an altered plaque morphology. These phenotypes also segregated with the large RNA segment. The importance of the large RNA segment (which encodes the viral polymerase) in neurovirulence contrasts with prior studies which indicate that the ability to cause lethal encephalitis after peripheral injection of suckling mice (neuroinvasiveness) is primarily determined by the middle-sized RNA segment, which encodes the viral glycoproteins.
To study the molecular determinants of viral virulence and neurotropism, we have focused on La Crosse virus, a member of the California serogroup of the family Bunyaviridae. Bunyavirus genomes are composed of three separate single-stranded RNA segments designated large (L), middlesized (M), and small (S). For members of the Bunyavirus genus, all three segments are of negative polarity (27) . The L RNA segment encodes the L protein, presumed to be the viral polymerase (4, 5) ; the M segment codes for the two structural glycoproteins (Gl and G2) and at least one nonstructural protein designated NSm (7) ; and the S RNA segment codes for the nucleocapsid protein (N) and the NS, nonstructural protein (2, 9, 10) . The trisegmented nature of the bunyavirus genome has permitted the construction of reassortant viruses between California serogroup viruses having different phenotypes. Reassortants have been used to map distinct phenotypes to specific gene segments, including electrophoretic mobilities of viral proteins, temperature sensitivity, plaque morphology, viral tropism, and viral virulence.
La Crosse virus and some other members of the California serogroup are associated with cases of human encephalitis in North America (14, 18, 23, 30, 32) . La Crosse virus infection of mice offers a good model system for the human disease and may be used to address questions concerning viral virulence and pathogenesis (15, 17) . In mice, the outcome of infection is dependent on the strain of virus, virus dose, route of infection, and age of the mice, variables which can be manipulated experimentally. The course of infection may be divided into two major phases, neuroinvasiveness and neurovirulence.
Neuroinvasiveness is a measure of the ability of a virus to invade the central nervous system (CNS) and produce * Corresponding author. disease after peripheral inoculation and encompasses the early stages of a natural infection, i.e., viral replication in extraneural tissues (primarily striated muscle), production of a plasma viremia, and spread to the CNS. Most California serogroup viruses are neuroinvasive, and those which are not exhibit restricted replication in peripheral tissues and consequently fail to invade the CNS (6, 15) . Genetic studies using reassortants show that neuroinvasiveness is primarily determined by the M RNA segment (11, 16, 28) . Furthermore, experiments with monoclonal antibody-resistant variant viruses implicate the Gi glycoprotein (which is encoded by the M RNA segment) in neuroinvasiveness (12) .
Neurovirulence, on the other hand, reflects the ability of a virus to replicate and produce disease in the CNS and can be quantitated as the ratio of PFU to 50% lethal doses (LD50) after intracerebral (i.c.) inoculation of adult mice. Adult mice injected i.c. with California serogroup viruses fail to develop a plasma viremia, and viral replication is restricted to the CNS (15, 17) . Therefore, i.c. challenge of adult mice constitutes an evaluation of neurovirulence uncomplicated by extraneural virus replication. All natural isolates of California serogroup viruses are highly neurovirulent, with a PFU/LD50 ratio of about 1 (13, 14) . A few neuroattenuated laboratory clones of California serogroup viruses have been described (25) , but these exhibited only minimal reduction in virulence.
Clone RFC/25 B.5 (B.5), derived by passage in BHK-21 cells, is the first highly neuroattenuated California serogroup virus to be described; it has a PFU/LD50 ratio of greater than 106 (6 Viruses and cell cultures. The origin and characterization of the neuroattenuated B.5 virus and the neurovirulent Bl-la virus have been previously described (6, 16 (la, 37) . BHK-21 and NA cells were propagated as previously described (6, 15) .
Plaque morphology and temperature sensitivity. Viruses were plaqued according to published protocols (6, 15, 16) . Medium was removed from subconfluent monolayers in six-well plates, and 0.2 ml of virus inoculum was added per well. After cultures were incubated at room temperature for 1 h on a rocker, an overlay consisting of 3 ml of 0.5% agarose in Eagle's minimum essential medium (MEM) with 2% fetal calf serum was added. Plaques were read after 3 days at 33 or 39.8°C in BHK-21 cells and after 3 or 5 days at 33°C in NA cells. Plaques were visualized by removing the agarose overlay and staining the remaining monolayer with amido black stain.
Preparation of reassortant viruses. Reassortant viruses were obtained by using a modified version of a published protocol (25) . Mixtures containing various concentrations of both B.5 and Bl-la viruses were precipitated overnight at 4°C in the presence of polyethylene glycol (7.1%, wt/vol) and 0.4 M NaCl. Viruses were pelleted by centrifugation at 10,000 x g for 30 min and resuspended in MEM containing 2% fetal bovine serum, 100 U of penicillin per ml, and 100 p.g of streptomycin per ml (infection medium). Confluent monolayers of BHK-21 cells that had been grown in 24-well plates (approximately 2 x 105 cells per well) were inoculated with 0.1 ml of resuspended virus mixture per well. Multiplicities of infection for each parent virus ranged from 1 to 200 PFU per cell, and parent viruses were not always present in equal amounts. After 2 h at 33°C, the supernatants were removed and the monolayers were washed extensively with MEM, refed with infection medium, and incubated at 33°C for an additional 16 to 24 h. Supernatants were harvested, clarified, and stored at -80°C. After three direct plaque purifications of these supernatants, individual virus clones were obtained Determination of viral genotypes. Triple-plaque-purified virus clones were genotyped by using a dot blot hybridization protocol previously described (5 is highly attenuated, both on i.c. injection of adult mice and on s.c. injection of suckling mice, reflecting the fact that it was passed 25 times in BHK-21 cells and selected for extreme attenuation (6) . Thus, the attenuation of clone B.5 is inconsistent with the virulence of the parent viruses from which it was derived, implying that it has acquired biologically significant mutations in one or more segments of its genome. This study was designed to identify which segment(s) was responsible for attenuation, by crossing clone B.5 with a neurovirulent reassortant of reciprocal genotype.
Clone Bl-la, of genotype LTT, was selected for this purpose, since it was highly neurovirulent ( The rates of reassortment were found to vary considerably among different coinfections, ranging from 0 to 27% (data not shown). Among those coinfections which yielded any reassortants, the frequency of reassortants was 21% (77 of 370), much lower than the 75% which would be expected assuming unrestricted segment reassortment. Among the six possible reassortant genotypes, there was considerable variation in relative frequency without any discernible pattern. There was only one reassortant of genotype TLT. To obtain further reassortants of this genotype, 148 additional clones were phenotyped, of which one was found with an XLT phenotype; on genotyping this proved to be another TLT virus.
Viruses of the LLT genotype were not observed in any of the initial coinfections, and a second round of coinfections was therefore performed by backcrossing an LLL reassortant clone (J18/8 virus) with Bl-la virus (LTT genotype).
Plaque-purified progeny viruses were then phenotyped by SDS-PAGE of 35S-labeled viral proteins. Phenotyping gene products of the M segment (Gl protein) and the S segment (N protein) was sufficient to obtain complete viral genotypes, since both parental viruses possessed a La Crosse virus-derived L RNA segment. Among 26 clones tested (data not shown), 13 were reassortants, including 8 with an LLT genotype.
Neurovirulence of reassortant viruses. To determine the neurovirulence of reassortant viruses, we titrated them i.c.
in adult mice and computed the ratios of PFU/LD50 at 14 days after infection (Fig. 1 Virulence is quantified as the log1o of the ratio PFU/LD_O. Bl-la virus, the survival time ranged from 6 to 9 days, depending on the dilution of virus. The few animals dying after injection of large doses of attenuated clone B.5 had a similar survival time.
Reassortants with an L RNA segment derived from the neurovirulent Bl-la virus (genotypes VAA, VAV, and VVA) were almost as neurovirulent as their virulent parent, and the mice died 6 to 9 days after infection. Reassortants with an L RNA segment derived from avirulent clone B.5 (AVA, AVV, and AAV) exhibited much lower virulence, but there was some variation among them. Reassortants with genotypes AVA and AVV were just as attenuated as the avirulent parent virus, B.5, in that they failed to kill mice at the lowest dilution tested (1:10) and had a computed ratio of over 105 PFU/LD50. Reassortants of genotype AAV showed slightly higher virulence, i.e., 103 to 105 PFU/LD50, computed 14 days after infection. These reassortants produced some long-incubation-period deaths, between 15 and 21 days after injection, that were not seen with any other reassortants. Consequently, the AAV reassortants were 100-to 250-fold more virulent when mortality at 21 days (rather than 14 days) postinfection was used in the computation of LD50 values.
These data indicated that the L RNA segment was the major determinant of the attenuation of avirulent clone B.5 but that clones bearing an L RNA segment derived from the attenuated parent varied in degree of attenuation. To confirm these differences, adult mice were injected i.c. with 700 PFU of both parental clones and of three selected reassortants, a virulent one, an avirulent one, and one of intermediate virulence, and the rate of viral replication in the brain was examined. Figure 2 shows that the virulent parental clone, Bl-la (genotype VVV), replicated to high titer by day 3 Temperature-sensitive phenotype. To map the temperature-sensitive phenotype of B.5 virus to the appropriate segment(s), reassortants were analyzed by a standard plaque assay on BHK-21 cells at both 33 and 39.8°C, and temperature sensitivity was expressed as the log1o (PFU at 33°C/PFU at 39.8°C). As shown in Table 2 , virulent clone Bl-la is not temperature sensitive, and its log1o ratio is 0.0; conversely, the log1o ratio of avirulent clone B.5 is 5.3. Among the reassortants, those with an L RNA segment from the virulent parent replicated well at 39.8°C (log1o ratios of 0.0 to 1.1), while those with an L RNA segment from the avirulent parent showed marked temperature sensitivity (log1o ratios of 3.8 to >6.2).
Plaque morphology and cellular host range. Avirulent clone B.5 exhibited a different plaque morphology than did virulent clone Bl-la and La Crosse and Tahyna viruses. In BHK-21 cells, clone B.5 produced smaller plaques than the virulent viruses, while in NA cells, clone B.5 produced a nonlytic focal plaque in contrast to the lytic plaques produced by the virulent viruses. When the reassortant clones were examined for plaque morphology (Table 2) , it appeared that clones bearing an L RNA segment from the virulent parent produced large plaques in BHK-21 cells and that clones bearing an L RNA segment from the avirulent parent produced small plaques. Likewise, reassortant clones bearing an L RNA segment from the virulent parent replicated well and produced lytic plaques in NA cells, while reassortants bearing an L RNA segment from the avirulent parent replicated slowly in NA cells and produced focal plaques or no plaques at all.
We suggested (6) that NA cells might serve as a surrogate for the mouse brain in that neuroattenuated clone B.5 replicated very poorly in these cells. To determine the specificity of this restriction, clone B.5 and parent La Crosse virus were compared for their abilities to replicate in four selected mouse cell lines (C2C12 mouse myoblasts, NIH 3T3 fibroblasts, L929 fibroblasts, and P388D1 monocytoid cells). Figure 3 shows that clone B.5 replicated poorly or not at all in these cell types, in contrast to its vigorous replication in BHK-21 cells. Therefore, it appears that the restriction of clone B.5 is not specific for cells of neuronal origin.
DISCUSSION
Genetic determinants of neuroattenuation. The neuroattenuated clone B.5 is the first available California serogroup virus which is highly attenuated upon i.c. injection, with a lethality ratio over 106-fold lower than those of wild-type strains or other viruses of the same genotype (Fig. 1) . This phenotype is not merely an expression of the inability of (6) .
There appears to be a hierarchy of mouse cell restriction of attenuated clone B.5 in which suckling mouse brain is at the most permissive end of the spectrum. This phenomenon is also seen with standard viruses, such as wild-type La Crosse/original virus (15) . These data on bunyaviruses are consistent with the longstanding observations that suckling mice are more permissive than older mice for a wide range of viruses (29, 33, 34) . After i.c. injection, viruses tend to replicate more rapidly and to higher titer in young mice, and this phenomenon is evident within hours, i.e., long before immune induction has occurred. The mechanism of this age-specific differential permissiveness has yet to be explained (34) .
The genetic studies reported here indicate that the L RNA segment is the major determinant of neurovirulence. This pattern contrasts sharply with the pattern of genetic determinants of neuroinvasiveness, since the M RNA segment, which encodes the viral glycoproteins, is primarily responsible for neuroinvasiveness (11, 16, 28 (20, 29, 31) . Certain strains of lymphocytic choriomeningitis virus are highly lethal in guinea pigs, with severe infection of lungs, lymph nodes, spleen, and adrenal glands, and lethality maps to the L RNA segment, which encodes the polymerase gene (24, 26) . Viral transcription, replication, and morphogenesis are all possible stages which could be affected by an altered viral polymerase, and further work is required to elucidate which aspect of polymerase function is associated with attenuation.
Temperature sensitivity. The major genetic determinant of temperature sensitivity also appears to be the L RNA segment, since the six reassortants carrying an L RNA segment from the virulent parent exhibit minimal temperature sensitivity, while the six reassortants carrying an L RNA segment from the avirulent parent exhibit marked temperature sensitivity. This is consistent with our prior observation that temperature-sensitive revertants also showed a marked increase in mouse neurovirulence (6) and may offer an approach to fine mapping of a virulence determinant in the L RNA segment.
It is important to emphasize that the reduced neurovirulence of clone B.5, and of reassortants bearing an L RNA segment derived from clone B.5, is not caused by their temperature sensitivity. Replication of these virus clones is restricted in mice, at their body temperature of 37°C (35) . In BHK-21 cells, clone B.5 replicates as well at 37 as at 33°C (Fig. 3) but is almost totally restricted at 39.8°C (6) . Furthermore, clone B.5 appears to have lost its neurotropism in mosquitoes which are maintained at 22°C (1). Thus, neuroattenuation and temperature sensitivity appear to be independent phenotypic manifestations of a mutation(s) in the L RNA segment.
Polygenic effects. Although the L RNA segment appears to be the major determinant of neurovirulence, of plaque morphology, and of temperature sensitivity, the patterns of attenuation are somewhat irregular among the six reassortants bearing the L segment from avirulent clone B.5. Thus, these six reassortants vary in degree of avirulence, in temperature sensitivity, and in restriction in NA cells. These observations suggest that other RNA segments modulate the effect of the L RNA segment, particularly on an avirulent genetic background. When the L RNA segment is derived from the virulent parent, this modulation is much less apparent. This polygenic effect resembles the findings with the nonneuroinvasive Tahyna/181-57 virus (16) , in which the M RNA segment was the dominant genetic determinant but the other two RNA segments modified the effect in reassortants bearing an M RNA segment derived from the attenuated parent.
In addition to its biologically altered L RNA segment, attenuated clone B.5 (genotype TLL) also has a mutation in its S RNA segment, since its N protein migrates more rapidly in PAGE than does the N protein of La Crosse/ original virus (6) . This mutation in the S RNA segment might contribute to the biological variability observed among reassortants with an attenuated L RNA segment.
